Provided by Tiger Trade Technology Pte. Ltd.

COMPASS Pathways plc

14.22
-0.9500-6.26%
Pre-market: 14.440.2200+1.55%07:29 EDT
Volume:3.32M
Turnover:47.40M
Market Cap:1.96B
PE:-3.94
High:15.01
Open:14.91
Low:14.00
Close:15.17
52wk High:15.87
52wk Low:4.82
Shares:138.00M
Float Shares:107.00M
Volume Ratio:1.06
T/O Rate:3.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.6118
EPS(LYR):-3.0800
ROE:-319.07%
ROA:-29.08%
PB:23.21
PE(LYR):-4.62

Loading ...

Compass Pathways Plc - Awarded Cnpv for Comp360 for Treatment-Resistant Depression

THOMSON REUTERS
·
Apr 24

Compass Pathways Announces FDA Granted Nda Rolling Review Request and Awarded Commissioner's National Priority Voucher

THOMSON REUTERS
·
Apr 24

BUZZ-Compass Pathways rises after FDA fast-tracks psychedelic drug research

Reuters
·
Apr 24

Enveric Biosciences up 3%, U.S.‑Listed Shares of Cybin Rise 4.5%

THOMSON REUTERS
·
Apr 24

Definium Therapeutics Adds 0.4%, Compass Pathways Rises 5.5%

THOMSON REUTERS
·
Apr 24

Psychedelic Drug Developers Rise After US FDA Moves to Fast-Track Drugs After Trump Order

THOMSON REUTERS
·
Apr 24

Compass Pathways Initiated at Buy by B. Riley Securities

Dow Jones
·
Apr 24

B. Riley Initiates COMPASS Pathways at Buy With $17 Price Target

MT Newswires Live
·
Apr 24

Stock Track | Compass Pathways Soars 7.21% in Pre-market After B. Riley Initiates Coverage with Buy Rating and $17 Target

Stock Track
·
Apr 24

Compass Pathways initiated with a Buy at B. Riley

TIPRANKS
·
Apr 24

Compass Pathways Plc : B. Riley Initiates Coverage With Buy Rating; Target Price $17

THOMSON REUTERS
·
Apr 24

EXPLAINER-What to know about psychedelic therapies cited by Trump

Reuters
·
Apr 22

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Whitehawk Therapeutics (WHWK), COMPASS Pathways (CMPS) and Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
Apr 21

Compass Pathways enters collaboration with Osmind

TIPRANKS
·
Apr 21

Compass Pathways collaborates with Osmind to prepare clinics for psychedelic treatments

Reuters
·
Apr 21

Stock Track | COMPASS Pathways Soars 9.20% in Pre-market After Trump's Executive Order Supports Psychedelic Treatments

Stock Track
·
Apr 21

Stock Track | COMPASS Pathways Soars 9.51% in Overnight Trading After Trump's Executive Order Supports Psychedelic Treatments

Stock Track
·
Apr 21

Psychedelic Stocks Surge After Trump Supports Using Drugs Like LSD for Mental Health

Dow Jones
·
Apr 21

NASD Most Active Issues

Dow Jones
·
Apr 21

Analysts Offer Insights on Healthcare Companies: COMPASS Pathways (CMPS) and Nuvalent (NUVL)

TIPRANKS
·
Apr 21